Speakers

Single-Use Technologies (SUTs) have shown remarkable technical advancement and market adoption over the past five years. Capital equipment cleaning, sterilization and labor costs comprise a substantial percentage of biopharmaceutical companies' manufacturing costs. The acceleration in adoption of single-use-technologies has aggressively transformed biotherapeutic protein and vaccine manufacturers' time-to-market, cost of goods and business models.

As an exclusive benefit to feature and benefit to BioProcess International readers and International Single-Use Summit attendees, the following speakers have provided brief audiocast previews or abstracts of their planned presentations. Click on the links below to learn more.

		Wynn Bailey Partner in the Pharmaceuticals & Life Sciences Advisory practice of PricewaterhouseCoopers Wynn will discuss the future of the biopharmaceutical supply chain. Preview now.			Eric Halioua, MBA Chief Executive Officer of Promethera Biosciences Eric will focus his discussion on single-use technologies for stem cell therapies. Preview now.
		Sarfaraz K. Niazi, Ph.D. Executive Chairman, Therapeutic Proteins Inc. President, Pharmaceutical Scientist Inc., Chicago, Illinois Dr. Niazi will discuss the acceptance and adoption of disposable processing systems. Preview now.			Jerold Martin Senior VP, Global Scientific Affairs Pall Life Sciences Jerold will discuss qualification, validation and best practice guides for single-use technologies. Preview now.
		.